CHELSEA ELLIS: Open Payments
NPI 1487078465 · WYOMING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 7 payments from 5 companies in 2025. Trend: 2023 $631 · 2024 $204 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Abbott Laboratories | 1 | $57 |
| PFIZER INC. | 2 | $39 |
| Gilead Sciences, Inc. | 1 | $29 |
| Verona Pharma, Inc. | 1 | $25 |
Products named: CAPLYTA, JOT DX, VYNDAQEL, Ohtuvayre.
Industry payments across MI — which companies pay providers there.
